A new clinical trial shows that adjusting specific fatty acid intake through diet significantly reduces the frequency and intensity of persistent post-traumatic headaches in individuals with traumatic brain injury.
A preliminary study suggests that a simple treatment algorithm can help reduce racial and ethnic disparities in multiple sclerosis care by increasing the use of highly effective therapies.
Deborah Jehu, PhD, highlights strategies for promoting physical activity while preventing falls in older adults.
An international team of researchers led by Penn Medicine will investigate the link between TBI and dementias over the next five years.
The real-world study evaluated the impact of this approach to address neuromuscular walking challenges associated with foot drop.
OneStep has secured $36 million to expand its smartphone-based gait analysis technology, aiming to make gait a widely-recognized "sixth vital sign" for health monitoring and disease management.
In people with primary progressive MS, a new study compared time before disability worsened between people receiving certain MS therapies and those not receiving treatment.
Black stroke patients arrive later to emergency departments, and EMS is less likely to notify hospitals of their condition ahead of time, a national study shows.
Cerevance has initiated the Phase 3 ARISE trial to evaluate solengepras, a non-dopaminergic therapy targeting specific brain circuits, as a potential adjunctive treatment for Parkinson's disease.